Providence, RI

Center for Medical Research, LLC

Hypertriglyceridemia

Alopecia

Alopecia Areata

Borrelia Infections

Heart Failure

Colorectal Cancer

Human Influenza

Erythema

Erythema Chronicum Migrans

Triglyceride

K-877

MHAA4549A

Baricitinib

LY3009104

BiDil

Kowa

Arbor Pharmaceuticals

Exact Sciences Corporation

Genentech

Lilly

Quidel

condition

allSponsorName

Incyte

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The reason for this study is to see if baricitinib is safe and effective in adults with severe or very severe alopecia areata (AA).

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

Center for Medical Research, LLC | Providence, RI

Site insights

Work at this site?

Active trials

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)

Trial sponsors